Atossa Therapeutics
ATOS
ATOS
54 hedge funds and large institutions have $11.9M invested in Atossa Therapeutics in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
20% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 15
41% less capital invested
Capital invested by funds: $20.2M → $11.9M (-$8.26M)
Holders
54
Holding in Top 10
–
Calls
$779K
Puts
$82K
Top Buyers
| 1 | +$124K | |
| 2 | +$98.4K | |
| 3 | +$94.3K | |
| 4 |
Two Sigma Investments
New York
|
+$85.3K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$41.3K |
Top Sellers
| 1 | -$273K | |
| 2 | -$91.7K | |
| 3 | -$56.5K | |
| 4 |
Jane Street
New York
|
-$45.3K |
| 5 |
Morgan Stanley
New York
|
-$34K |